Autoregulation of angiogenesis by cells of the vessel wall

International Review of Cytology

Volumn 185, Issue , 1998, Pages 1-43

  Nicosia, R F ^a   Villaschi, S ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Angiogenesis; Endothelium; Extracellular matrix; Fibroblasts; Growth factors; Matrix metalloproteinases; Pericytes; Plasminogen activators; Smooth muscle cells

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN GEL; GROWTH FACTOR; PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; AORTA; AUTOREGULATION; CELL INTERACTION; EXPLANT; EXTRACELLULAR MATRIX; FIBROBLAST; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; REVIEW; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLASTS; GROWTH SUBSTANCES; HOMEOSTASIS; MODELS, CARDIOVASCULAR; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; REGENERATION; VASODILATION;

EID: 0031705731     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)60148-5     Document Type: Article

References (237)

1. Akita , M., Murata, E., Merker, H. J., and Kaneko, K. (1997). Formation of new capillary-like tubes in a three-dimensional in vitro model (aorta/collagen gel). Anatomischer Anzeiger. 179, 137-147.
2. Antoniades, H. N., Stathakos, D., and Scher, C. D. (1975). Isolation of a cationic polypeptide from human serum which stimulates the proliferation of 3T3 cells. Proc. Natl. Acad. Sci. USA 72, 2635-2639.
3. Antoniades, H. N., Galanopoulos, T., Neville-Golden, J., Kiritsy, C. P., and Lynch, S. E. (1991). Injury induces in vivo expression of PDGF and PDGF receptor mRNA in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc. Natl. Acad. Sci. USA 88, 565-569.
4. Ausprunk, D., Falterman, K., and Folkman, J. (1978). The sequence of events in the regression of corneal capillaries. Lab. Invest. 38, 284-294.
5. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., and Yayon, A. (1994). Perlecan, a basement lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005-1013.
6. Bacharach, E., and Keshet, E. (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA 89, 10686-10690.
7. Baker, J., Liu, J. P., Robertson, E. J., and Esfratiadis, A. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82.
8. Bar, R. S. (1992). Vascular endothelium and diabetes mellitus. In "Endothelial Cell Dysfunctions" (N. Simionescu and M. Simionescu, Eds.), pp. 363-381. Plenum, New York.
9. Bar, R. S., Boes, M., Dake, B. L., Henley, S., and Hart, M. N. (1989). The effects of platelet-derived growth factor in cultured microvessel endothelial cells. J. Endocrinol. 124, 1841-1848.
10. Barger, A. C., Beeuwkes, R., III, and Lainey, L. L. (1984). Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. N. Engl. J. Med. 310, 175-177.
11. Barnathan, E. S., Kuo, A., Rosenfeld, L., Kariko, K., Leski, M., Robbiati, F., Nolli, M. L., Henkin, J., and Cines, D. B. (1990). Interaction of single chain-urokinase-type plasminogen activator with human endothelial cells. J. Biol. Chem. 265, 2865-2872.
12. Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. (1995). Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83-87.
13. Ben-Ezra, D. (1978). Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am. J. Ophtalmol. 86, 455-461.
14. Berk, B. C, Alexander, W., Brock, T. A., Gimbrone, M. A., and Clinton Webb, R. (1986). Vasoconstriction: A new activity for platelet-derived growth factor. Science 23, 87-90.
15. Bobik, A., Groms, A., Millar, J. A., Mitchell, A., and Grinpukel, S. (1990). Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 258, C40S-C415.
16. Borgstrom, P., Hillan K. J., Pragada, S., and Ferrara, N. (1996). Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56, 4032-4039.
17. Bouchard, B. A., Shatos, M. A., and Tracy, P. B. (1997). Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscl. Thromb. Vasc. Biol. 17, 1-9.
18. Brogi, E., Wu, T., Namiki, A., and Isner, J.M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-652.
19. 3 for angiogenesis. Science 264, 569-571.
20. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., StetlerStevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693.
21. Brown, J., Maynes, S.F., Bezos, A., Maguire, D.J., Ford, M.D., and Parish, R., (1996). A novel in vitro assay of human angiogenesis. Lab. Invest. 75, 539-555.
22. Brown, L.F., Yeo, K.T., Berse, B., Yeo, T.K., Senger, D.R., and Dvorak, H.F. (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379.
23. Bussolino, F., DiRenzo, M. F., Ziehe, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
24. Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, I., Deminck, H., Kasper, M., Breier, G., Evrard, P., Muller, M., Risau, W., Edgington, T., and Collen, D. (1996). Role of tissue factor in embryonic tissue development. Nature 383, 73-75.
25. Carmeliet, P., Moons, L., Dewechin, M., Mackman, N., Luther, T., Breier, G., Plopis, V., Muller, M., Nagy, A., Plow, E., Gerard, R., Edgington, T., Risau, W., and Collen, D. (1997a). Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor and the plasminogen system. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 191-204. New York Academy of Sciences, New York.
26. Carmeliet, P., Moons, L., Plopis, V., Plow, E., and Collen, D. (1997b). Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99, 200-208.
27. Christ, B., Poelmann, R. E., and Mentink, M. M. T. (1990). Vascular endothelial cells migrate centripetally within embryonic arteries. Anat. Embryol. 181, 333-339.
28. Clark, E. R., and Clark, E. L. (1939). Microscopic observation on the growth of blood capillaries in the living mammal. Am. J. Anat. 64, 251-299.
29. Coffer, A., Fellows, J., Young, S., Pappin, D., and Rahman, D. (1991). Purification and characterization of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium. Biochem. J. 278, 35-41.
30. Contrino, J., Hair, G., Kreutzer, D. L., and Rickles, F. R. (1996). In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nature Med. 2, 209-215.
31. Cordon-Cardo, C., Vlodavsky, I., Haimovitz-Friedman, A., Hicklin, D., and Fuks, Z. (1990). Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest. 63, 832-840.
32. Cornelius, L. A., Nehering, L. C., Roby, J. D., Parks, W. C., and Welgus, H. G. (1995). Human dermal microvascular endothelial cells produce matrix metalloproteases in response to angiogenic factors and migration. J. Invest. Dermatol. 105, 170-176.
33. Couffmhal, T., Kearney, M., Witzenbichler, B., Chen, D., Murohara, T., Losordo, D. W., Symes, J., and Isner, J. M. (1997). Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am. J. Pathol. 150, 1673-1685.
34. Cromack, D. T., Sporn, M. B., Roberts, A. B., Merino, M. J., Dart, L. L., and Norton, J. (1987). Transforming growth factor β levels in rat wound chambers. J. Surg. Res. 42, 622-628.
35. D'Amore, P., and Smith, S. R. (1993). Growth factor effects on cells of the vascular wall: A survey. Growth Factors 8, 61-75.
36. Davis, S., Aldrich, T. H., Jones, P. F., Acherson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., and Yancopoulos, G. D. (1996). Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169.
37. Dejana, E. (1996). Endothelial adherens junctions: Implications in the control of vascular permeability and angiogenesis. J. Clin. Invest. 98, 1948-1953.
38. Dejana, E., Valiron, O., Navarro, P., and Lampugnani, M. G. (1997). Intercellular junctions in the endothelium and control of vascular permeability. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 33-44. New York Academy of Sciences, New York.
39. Delafontaine, P., Lou, H., and Alexander, R. W. (1991). Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 18, 742-747.
40. DeLissler, H. M., Christofidou-Solomidou, M., Strieter, R. M., Burdick, M. D., Robinson, C. S., Wexler, R. S., Kerr, J. S., Garlanda, C., Menvin, J. R., Madri, J. A., and Albelda, S. M. (1997). Involvement of endothelial PECAM- 1/CD31 in angiogenesis. Am. J. Pathol. 151, 671-677.
41. Desmouliere, A., Geinoz, A., Gabbiani, F., and Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing culture fibroblasts. J. Cell Biol. 122, 103-111.
42. Diaz-Flores, L., Gutierrez, R., and Varela, H. (1992). Behavior of postcapillary venule pericytes during postnatal angiogenesis. J. Morphol. 213, 33-45.
43. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkharni, A. B., Karlsson, S., and Akhurst, R. J. (1995). Defective hematopoiesis and vasculogenesis in transforming growth factor beta-1 knock out mice. Development 121, 1845-1854.
44. Dingemans, K. P., Jansen, N., and Becker, A. E. (1981). Ultrastructure of the normal human aortic media. Virchows Arch. Pathol. Anat. 392, 199-216.
45. Dluz, S. M., Higashiyama, S., Damm, D., Abraham, J. A., and Klagsburn, M. (1993). Heparin binding EGF like growth factor expression in cultured fetal human vascular smooth muscle cells: Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 268, 18330-18334.
46. Donahue, S., and Pappas, G. D. (1961). The fine structure of capillaries in the cerebral cortex of the rat at various stages of development. Am. J. Anat. 108, 331-347.
47. Drexler, H., Schnurch, H., Breier, G., and Risau, W. (1992). Regulation of embryonic blood vessel formation. In "Angiogenesis in Health and Disease" (M. E. Maragoudakis, P. Gullino, and P. I. Lelkes, Eds.), NATO ASI Series, Vol. 227, pp. 17-25. Plenum, New York.
48. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am. J. Pathol. 36, 139-155.
49. Enholm, B., Paavonen, K., Ristimaki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U., and Alitalo, K. (1997). Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14, 2475-2483.
50. Ferrara, N., Winer, J., and Burton, T. (1991). Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 5, 141-148.
51. Ferrara, N., Houck, K., Jakeman, L., and Leung, D.(1992). Molecular and biological properties of the vascular endothelial growth factor. Endocr. Rev. 13, 18-32.
52. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
53. Fine, A., and Goldstein, R. H. (1987). The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262, 3897-3902.
54. Finkenzeller, G., Marme, D., Weich, H. A., and Hug, H. (1992). Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res. 52, 4821-4823.
55. Folkman, J. (1985). Toward an understanding of angiogenesis: Search and discovery. Perspect. Biol. Med. 29, 10-36.
56. Folkman, J, (1995). Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763.
57. Folkman, J. (1996). Fighting cancer by attacking its blood supply. Sci. Am. 275, 150-154.
58. Folkman, J., and Cotran, R. (1976). Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol. 16, 207-248.
59. Fong, G., Rossant, J., Gertsestein, M., and Breltman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
60. Forough, R., Koyama, N., Hasenstab, D., Lea, H., Clowes, M., Nikkari, S., and Clowes, A. (1996). Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth cell functions in vitro and in vivo. Circ. Res. 79, 812-820.
61. Fournier, N., and Doillon, C. J. (1992). In vitro angiogenesis in fibrin matrices containing fibronectin or hyaluronic acid. Cell Biol. Int. Rep. 16, 1251-1263.
62. Frater-Schroder, M., Risau, W., Hallman, R., Gautschi, R., and Bohlen, P. (1987). Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro. Proc. Natl. Acad. Sci. USA 84, 5277-5281.
63. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995). Science 270, 1500-1502.
64. Gabbiani, G., Ryan, G. B., and Majno, G. (1971). Presence of modified fibroblasts in granulation tissue and their role in wound contraction. Experientia 27, 549-550.
65. Galis, Z. S., Sukhova, G. K., Lark, M. W., and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503.
66. Garg, U. C., and Hassid, A. (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83, 1774-1777.
67. George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H., and Hynes, R. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079-1091.
68. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. (1997). Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660.
69. Gimbrone, M. A., Resnick, N., Nagel, T., Khachgian, L. M., Collins, T., and Topper, J. N. (1997). Hemodynamics, endothelial gene expression, and atherogenesis. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 1-11. New York Academy of Sciences, New York.
70. Gorlin, R. J. (1997). Fibroblast growth factors, their receptors and receptor disorders. J. Cranio-Maxillo-Facial Sttrg. 25, 69-79.
71. Gospodarowicz, D., and Neufeld, G. (1986). Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ. 19, 1-17.
72. Grabowski, E. F., and Lam, F. P. (1995). Endothelial cell function, including tissue factor expression, under flow conditions. Thromb. Haemostasis 74, 123-128.
73. Gross, J. L., Moscatelli, D., Jaffe, E. A., and Rifkin, D. (1982). Plasminogen activator and collagenase production by cultured capillary endothelial cells. J. Cell Biol. 95, 974-981.
74. Guinec, N., Dalet-Fumeron, V., and Pagano, M. (1993). In vitro study of basement membrane degradation by the cystein proteases, cathepsin B, B-like and L. Digestion of collagen IV, laminin, fibronectin and release of gelatinase activities from basement membrane fibronectin. Biol. Chem. Hoppe-Seyler 374, 1135-1146.
75. Hannan, R. L., Kourembanas, S., Flanders, K. C., Rogelj, S. J., Roberts, A. B., Fallers, D. V., and Klagsburn, M. (1988). Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors 1, 7-17.
76. Hansson, H. A., Brandsten, C., Lossing, C., and Petruson, K. (1989). Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis. Exp. Mol. Pathol. 50, 125-138.
77. Hart, C. E., Bailey, M., Curtis, D. A., Osborn, S., Raines, E., Ross, R., and Forstrom, J. W. (1990). Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29, 166-172.
78. Hawker, J. R., and Granger, H. J. (1994). Tyrosine kinase inhibitors impair fibroblast growth factor signaling in coronary endothelial cells. Am. J. Physiol. 266, H107-H1120.
79. Haymann, E. G., Pierschbacher, M. D., and Ruoslathi, E. (1985). Detachment of cells from culture substrate by soluble fibronectin peptides. J. Cell Biol. 100, 1948-1954.
80. Higashiyama, S., Abraham, J., Miller, J., Fiddes, J. C., and Klagsburn, M. (1992). Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure and glycosylation of the mature protein. J. Biol. Chem. 267, 6205-6212.
81. Hirakow, R., and Hiruma, J. (1983). TEM-studies on development and canalization of the dorsal aorta in the chick embryo. Anat. Embryol. 163, 299-306.
82. Hlatky, L., Tsionou, C., Hahnfeldt, P., and Coleman, N. (1994). Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up regulation and protein expression. Cancer Res. 54, 6083-6086.
83. Homandberg, G. A., Williams, J. E., Grant, D., Schumacher, B., and Eisenstein, R. (1985). Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am. J. Pathol. 120, 327-332.
84. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 269, 4355-4361.
85. Hughes, S. E., Crossman, D., and Hall, P.A. (1993). Expression of basic and acidic fibroblast growth factors and their receptors in normal and atherosclerotic human arteries. Cardiovasc. Res. 27, 1214-1219.
86. Hynes, R. O. (1992). Integrins, a family of cell surface receptors. Cell 48, 549-555.
87. Ingber, D. (1991). Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J. Cell. Biochem. 47, 236-241.
88. Ingber, D., and Folkman, J. (1989). How does extracellular matrix control capillary morphogenesis? Cell 59, 803-805.
89. Isner, J. M., Walsh, K., Symes, J., Pieczek, A., Takeshita, S., Lowry, J., Rosenfield, K., Weir, L., Brogi, E., and Jurayj, D. (1996). Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7, 959-988.
90. Itoh, T., Tamioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
91. Jakob, W., Jentzch, K. D., Mauersberger, B., and Oehme, P. (1977). Demonstration of angiogenesis activity in the corpus luteum of cattle. Exp. Pathol. 13, 231-236.
92. Kainulainen, V., Nelimarkka, L., Jarvelainen, H., Laato, M., Jalkanen, M., and Elenius, K. (1996). Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J. Biol. Chem. 271, 18759-18766.
93. Kawasaki, S., Mori, M., and Awai, M. (1989). Capillary growth of rat aortic segments cultured in collagen without serum. Acta Pathol. Japonica 39, 712-718.
94. Kazlauskas, A., and DiCorleto, P. E. (1985). Cultured endothelial cells do not respond to a platelet-derived growth factor-like protein in an automne manner Biochim. Biophys. Acta 846, 405-412.
95. Kennedy, S. H., Rouda, S., Quin, H., Aho, S., Selber, J., and Tan, E. M. (1997). Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells. J. Cell. Biochem. 65, 32-41.
96. Khorsandi, M. J., Fagin, J.A., Giannella-Neto, D., Forrester, J. S., and Cercek, B. (1992). Regulation of insulin-like growth factor I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J. Clin. Invest. 90, 1926-1931.
97. King, G. L., Goodman, A. D., Buzney, S., Moses, A., and Kahn, C. R. (1985). Receptors and growth promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J. Clin. Invest. 75, 1028-1036.
98. Kleinmann, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. B., and Martin, G. R. (1986). Basement membrane complexes with biological activity. Biochemistry 25, 312-318.
99. Knedler, A., and Ham, R. (1987). Optimized medium for clonal growth of human microvascular endothelial cells with minimal serum. In Vitro Cell. Dev. Biol. 23, 481-491.
100. Knighton, D. R., Phillips, G. D., and Fiegel, V. D. (1990). Wound healing angiogenesis: Indirect stimulation by basic fibroblast growth factor. J. Trauma 30(Suppl. 12), S134-S144.
101. Koch, A. C., Friedman, J., Burrows, J. C., Haines, G. K., and Bouck, N. P. (1993). Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology 61, 1-6.
102. Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. (1995). Angiogenesis is mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517-519.
103. Ku, D. D., Zaleski, J. K., Liu, S., and Brock, T. A. (1993). Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265, H586-H592.
104. Kubota, Y., Kleinmann, H., Martin, G. R., and Lawley, T. J. (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107, 1589-1598.
105. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., and Alitalo, K. (1997). VEGF-C receptor binding and pattern expression with VEGF-3 suggests a role in lymphatic vascular development. Development 122, 3829-3837.
106. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S. (1993). Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774.
107. Kurihara, H., Kurihara, Y., Maemura, K., and Yazaki, Y. (1997). The role of endothelin-1 in cardiovascular development. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 168-177. New York Academy of Sciences, New York.
108. Ladoux, A., and Frelin, C. (1993). Expression of vascular endothelial growth factor by cultured endothelial cells from brain microvessels. Biochem. Biophys. Res. Commun. 194, 799-803.
109. Lamszus, K., Joseph, A., Jin, L., Yao, Y., Chowdhury, S., Fuchs, A., Polverini, P. J., Goldberg, I. D., and Rosen, E. M. (1996). Scatter factor binds thrombospondin and other extracellular matrix components. Am. J. Pathol. 149, 805-819.
110. Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., and Nuseir, N. (1987). Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329, 630-632.
111. Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A., and Koch, A. E. (1994). Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide synthasedependent effector mechanism. Proc. Natl. Acad. Sci. USA 91, 4190-4194.
112. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E., and Betsholtz, C. (1994). Mice deficient for PDGFB show renal, cardiovascular and hematological abnormalities. Genes Dev. 8, 1875-1887.
113. Lindner, V. (1995a). Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury. Z. Kardiol. 4, 137-144.
114. Lindner, V. (1995b). Expression of platelet-derived growth factor ligands and receptors by rat aortic endothelium in vivo. Pathobiology 63, 257-264.
115. Lindner, V., and Reidy, M. (1993). Expression of fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ. Res. 73, 589-595.
116. Liotta, L. A., Goldfarb, R. H., Brundage, R., Siegal, G. P., Terranova, V., and Garbisa, S. (1981). Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of the basement membrane. Cancer Res. 41, 4629-4636.
117. Loskutoff, D. J., and Edgington, T. E. (1979). Synthesis of a flbrinolytic activator by endothelial cells. Proc. Natl. Acad. Sci. USA 74, 3903-3907.
118. Lu, T. T., Yan, L. G., and Madri, J. A. (1996). Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc. Natl. Acad. Sci. USA 93, 11808-11813.
119. Luscher, T. F., and Wenzel, R. R. (1995). Endothelin and endothelin antagonists: Pharmacology and clinical implications. Agents Actions (Suppl.) 45, 237-253.
120. Lutty, G. A., Liu, S. A., and Prendergast, R. A. (1983). Angiogenic lymphokines of activated T-cell origin. Inv. Optiialmol. Vis. Sci. 24, 1595-1603.
121. Madri, J. A., Pratt, B. M., and Tucker, A. M. (1988). Phenotypic modulation of endothelial cells by transforming growth factor-β depends on the composition and organization of the extracellular matrix. J. Cell Biol. 106, 1375-1384.
122. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Sato, T. N., and Yancopoulos, G. D. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
123. Majack, R. A., Majesky, M. W., and Goodman, L. V. (1990). Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J. Cell Biol. 111, 239-247.
124. Majesky, M. W., Benditt, E. P., and Schwartz, S. M. (1988). Expression and developmental control of platelet-derived growth factor A-chain and B-chain/sis genes in rat aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA 85, 1524-1528.
125. Majesky, M. W., Lindner, V., Twardzik, D. R., Schwartz, S. M., and Reidy, M. A. (1991). Production of transforming growth factor β1 during repair of arterial injury. J Clin. Invest. 88, 904-910.
126. Masferrer, J. L., Murphy, R. C., Pagano, P. J., and Dunn, M. W. (1989). Ocular effects of a novel cytochrome P-450-dependent arachidonic acid metabolite. Invest. Ophtalmol. Vis. Sci. 30, 454-460.
127. Massague, J. (1990). The transforming growth factor-family. Annu. Rev. Cell Biol. 6, 597-641.
128. Matsuma, J., Wolff, K., and Petzelbauer, P. (1997). Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J. Immunol. 158, 3408-3416.
129. Meininger, C. J., and Zetter, B. R. (1992). Mast cells and angiogenesis. Sem. Cancer Biol. 3, 73-79.
130. Mignatti, P., and Rifkin, D. B. (1991). Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: A trivial phenomenon or a novel secretion mechanism? J. Cell Biochem. 47, 201-207.
131. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic basement membrane: Requirement for basic fibroblast growth factor-induced proteinases. J. Cell Biol. 108, 671-682.
132. Millauer, B., Wizigmann-Woos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A. (1993). High affinity binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
133. Millauer, B., Shawer, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
134. Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C. L., Stratton-Thomas, J. R., Shuman, M. A., and Rosenberg, S. (1996). Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 56, 2428-2433.
135. Minakawa, T., Bready, J., Berliner, J., Fisher, M., and Cancilla, P. A. (1991). In vitro interactions of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium. Lab. Invest. 65, 32-40.
136. Minchenko, A., Bauer, T., Salceda, S., and Caro, J. (1994). Hypoxie stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71, 374-379.
137. Moncada, S. (1997). Nitric oxide in the vasculature: Physiology and pathophysiology. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 60-69. New York Academy of Sciences, New York.
138. Montesano, R., Orci, L., and Vassalli, J. D. (1983). In vitro rapid organization of endothelial cells is promoted by collagen matrices. J. Cell Biol. 97, 1648-1652.
139. Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., and Orci L. (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83, 7297-7301.
140. Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., and Ziehe, M. (1996). Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270, H411-H415.
141. Moscatelli, D., and Rifkin, D. (1988). Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 498, 67-85.
142. Moses, M. A., Klagsburn, M., and Shing, Y. (1995). The role of growth factors in vascular cell development and differentiation. Int. Rev. Cytol. 161, 1-48.
143. Mutsukrishnan, L., Warder, E., and McNeil, P. (1991). Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell. Physiol. 148, 1-16.
144. Nehls, V., Denzer, K., and Drenckhahn, D. (1992). Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res. 270, 469-474.
145. Nguyen, M., Strubel, N. A., and Bischoff, J. (1993). A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365, 267-269.
146. Nicosia, R. F. (1998). The rat aorta model of angiogenesis and its applications. In "Vascular Morphogenesis in Vivo, in Vitro and in Mente" (C. Little, H. Sage, and V. Mironov, Eds.). Birkhauser, Cambridge, MA, (in press).
147. Nicosia , R. F., and Bonanno, E.(1991). Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am. J. Pathol. 138, 829-833.
148. Nicosia, R. F., and Madri, J. A. (1987). The microvascular extracellular matrix: Developmental changes during angiogenesis in the aortic-ring plasma clot model. Am. J. Pathol. 128, 78-90.
149. Nicosia, R. F., and Ottinetti, A. (1990). Growth of microvessels in serum-free matrix culture of rat aorta: A quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122.
150. Nicosia, R. F., and Villaschi, S. (1995). Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab. Invest. 73, 658-666.
151. Nicosia, R. F., Tchao, R., and Leighton, J. (1982). Histotypic angiogenesis in vitro: Light microscopic, ultrastructural, and radioautographic studies. In Vitro 18, 538-549.
152. Nicosia, R. F., Bonanno, E., and Smith, M. (1993). Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J. Cell. Physiol. 154, 654-661.
153. Nicosia, R. F., Bonanno, E., and Yurchenco, P. (1994a). Modulation of angiogenesis in vitro by laminin-entactin complex. Dev. Biol. 164, 197-206.
154. Nicosia, R. F., Nicosia, S. V., and Smith, M. (1994b). Vascular endothelial growth factor, platelet derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 145, 1023-1029.
155. Nicosia, R. F., Villaschi, S., and Smith, M. (1994e). Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell. Dev. Biol. 30A, 394-399.
156. Nicosia, R. F., Lin, Y. J., Hazelton, D., and Qian, X. (1997). Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am. J. Pathol. 151, 1379-1386.
157. Nissanov, J., Tuman, R. W., Gruver, L.M., and Fortunato, J.M. (1995). Automatic vessel segmentation and quantification of the rat aortic ring assay of angiogenesis. Lab. Invest. 73, 734-739.
158. O'Brien, E., Garvin, M. R., Stewart, D., Hinohara, T., Simpson, J. B., Schwartz, S., and Giachelli, C. M. (1994). Osteopontin is synthesized by macrophages, smooth muscle and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscl. Thromb. 14, 1648-1656.
159. Odedra, R., and Weiss, J. B. (1991). Low molecular weight angiogenesis factors. Pharmacol. Ther. 49, 111-124.
160. O'Donaghue, M. N., and Zarem, H. A. (1971). Stimulation of neovascularization: Comparative efficacy of fresh and preserved skin grafts. Plastic Reconstr. Surg. 48, 474-478.
161. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692.
162. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
163. Orlidge, A., and D'Amore, P. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105, 1455-1462.
164. Pepper, M. S., Vassalli, J. D., Montesano, R., and Orci, L. (1987). Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol. 105, 2535-2541.
165. Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1991). Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial .cells. Biochem. Biophys. Res. Commun. 181, 902-906.
166. Pepper, M., Ferrara, N., Orci, L., and Montesano, R. (1993a). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824-831.
167. Pepper, M., Vassalli, J. D., Orci, L., and Montesano, R. (1993b). Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp. Cell Res. 204, 356-363.
168. Pietrzkowski, Z., Sell, C., Lammers, R., Ullrich, A., and Baserga, R. (1992). Roles of insulin-like growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol. Cell. Biol. 12, 3883-3889.
169. Pipili-Synetos, E., Sakkoula, E., and Maragoudakis, M. E. (1993). Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108, 855-857.
170. Powell, P., Klagsburn, M., Abraham, J., and Jones, R. (1993). Eosinophil expressing heparin-binding localizes around microvessels in pulmonary hypertension. Am. J. Pathol. 143, 784-793.
171. Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A., and Partanen, J. (1995). The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14, 5884-5891.
172. Qian, X., Wang, T. N., Rothman, V. L., Nicosia, R. F., and Tuszynski, G. P. (1997). Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial Cells. Exp. Cell Res. 235, 403-412.
173. Quinn, T., Peters, K. G., deVries, C., Ferrara, N., and Williams, L. T. (1993). Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7537.
174. Ray , J. M., and Stetler-Stevenson, W. G. (1994). The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
175. RayChaudury , A., and D'Amore, P. A. (1991). Endothelial cell regulation by transforming growth factor-beta. J. Biol. Chem. 47, 224-229.
176. Reidy, M., Irvin, C., and Lindner, V. (1996). Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78, 405-414.
177. Rhodin, J. A. G., and Fujita, H. (1989). Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analysis. J. Submicrosc. Cytol. Pathol. 21, 1-34.
178. Risau, W., Sariola, H., Zerwes, H. G., Sasse, J., Ekblom, P., Kemler, R., and Doetschmann, T. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102, 471-478.
179. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, O., Roche, L., Falania, V., Lehrl, J. H., and Fauci, A. S. (1986). Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171.
180. Roletto, F., Galvani, A. P., Cristiani, C., Valsasina, B., and Landonio, A. (1996). Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. J. Cell. Physiol. 166, 105-111.
181. Rooney, P., Kumar, S., Ponting, J., and Wang, M. (1995). The role of hyaluronan in tumor neovascularization. Int. J. Cancer 60, 632-636.
182. Root, L. L., and Shipley, G. D. (1991). Human dermal fibroblasts express multiple bFGF and aFGF proteins. In Vitro Cell. Dev. Biol. 27A, 815-822.
183. Rosen, E. M., and Goldberg, I. D. (1997). Regulation of angiogenesis by scatter factor. EXS 79, 193-208.
184. Rosen, E. M., Grant, D., Kleinmann, H., Jaken, S., Donovan, M. A., Setter, E., Luckett, P. M., Carley, W., Bhargava, M., and Goldberg, I. D. (1991). Scatter factor stimulates the migration of vascular endothelium and capillary-like tube formation. EXS 59, 76-88.
185. Ross, R., Glomset, J. A., Kariya, B., and Harker, L. (1974). A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA 71, 1207-1210.
186. Saskela, O. (1985). Plasminogen activator and the regulation of pericellular proteolysis. Biochim. Biophys. Acta 823, 35.
187. Saskela, O, and Rifkin, D. B. (1990). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110, 767-775.
188. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65.
189. Sato, N., Sawasaki, Y., Senoo, A., Fuse, Y., Hirano, Y., and Goto, T. (1987). Development of capillary networks from rat microvascular fragments in vitro: The role of myofibroblastic cells. Microvasc. Res. 33, 194-210.
190. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Bulcholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
191. Sato, Y., Shimada, T., and Takaki, R. (1991). Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro. Biochem. Biophys. Res. Commun. 180, 1098-1102.
192. Sato, Y., Asada, Y., Marutsuka, K., Hatakeyama, K., and Sumiyoshi, A. (1996). Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb. Hemostasis 75, 389-392.
193. Schatteman, G.C., Motley, S. T., Effman, E. L., and Bowen-Pope, D. F. (1995). Platelet-derived growth factor receptor alpha-subunit deleted Patch mouse exhibits severe cardiovascular dysmorphogenesis. Teratology 51, 351-366.
194. Schnaper, W. H., Grant, D. S., Stetler-Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., and French, D. L. (1993). Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156, 235-246.
195. Schoefl, G. I. (1963). Studies on inflammation III. Growing capillaries: Their structure and permeability. Virchows Arch. (Pathol. Anat.) 337, 97-141.
196. Schwartz, S. M., Heimark, R. L., and Majesky, M. W. (1990). Developmental mechanisms underlying the pathology of arteries. Physiol. Rev. 70, 1177-1209.
197. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J., Fiddes, J. C., and Gospodarowicz, D. (1987). Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325, 257-259.
198. Seifert, R. A., Hart, C. E., Philips, P. E., Forstrom, J. W., Ross, R., Murray, M. J., and BowenPope, D. F. (1988). Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264, 8771-8778.
199. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
200. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertenstein, M., Wu, X. F., Breltman, M. L., and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
201. Sims, D. E. (1986). The pericyte - A review. Tissue Cell 18, 153-174.
202. Smits, A., Hermansson, M., Nister, M., Karnushina, I., Heldin, C. H., Westermark, B., and Funa, K. (1989). Rat brain capillary endothelial cells express functional PDGF-B-type receptors. Growth Factors 2, 1-8.
203. Sporn, M. B., Roberts, A. B., Wakefield, L. M., and De Crombrugghe, B. (1987). Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105, 1039-1045.
204. Stewart, P. A., and Wiley, M. J. (1981). Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells. Dev. Biol. 84, 183-192.
205. Sueishi, K., Yoshikazu, Y., Nakagawa, K., Kaneda, Y., Kumamoto, M., and Nakashima, Y. (1997). Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in animal model induced by the gene transfer of vascular endothelial growth factor. In "Atherosclerosis IV" (F. Numano and R. Ross, Eds.), Vol. 811, pp. 311-324. New York Academy of Sciences, New York.
206. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. (1994). Macrophages and angiogenesis. J. Leukocyte Biol. 55, 410-422.
207. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
208. Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L., Bunting, S., Ferrara, N., Symes, J., and Isner, J. (1994). Therapeutic angiogenesis. A single intrarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670.
209. Taubman, M. B. (1993). Tissue factor regulation in vascular smooth muscle: A summary of studies performed using in vivo and in vitro models. Am. J. Cardiol. 72, 55C-60C.
210. Terman, B. I., Vermazen, M. D., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. (1992). Identification of the KDR tyrosinase kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 34, 1578-1586.
211. Thoma, R. (1911). Ueber die histomechanik des gefasssystems und die pathogenese der angiosklerose. Virchow Arch. Pathol. Anat. Physiol. 204, 1-74.
212. Tonnesen, M. G., Jenkins, D., Siegal, S., Lee, L. A., Huff, J. C., and Clark, R. A. F. (1985). Expression of fibronectin, laminin and factor VIII-related antigen during development of the human cutaneous microvasculature. J. Invest. Dermatol. 85, 564-568.
213. Unemori, E. N., Ferrara, N., Bauer, E. A., and Amento, E. P. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 153, 557-562.
214. van Hinsbergh, V. W., Koolwijk, P., and Hanemaaijer, R. (1997). Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells. EXS 79, 391-411.
215. Vernon, R. B., Lara, S. L., Drake, C. J., Iruela-Arispe, M. L., Angello, J. C., Little, C. D., Wight, T. N., and Sage, E. H. (1995). Organized type I collagen influence endothelial patterns during "spontaneous angiogenesis in vitro": Planar cultures as models of vascular development. In Vitro Cell. Dev. Biol. Anim. 31, 120-131.
216. Vikkula, M., Boon, L. M., Carraway, K. L., Calvert, J. T., Diamonti, A. J., Goumnerov, B., Pasyk, K. A., Marchuk, D. A., Warman, M. L., Cantley, L. C., Mulliken, J. B., and Olsen, B. (1996). Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181-1190.
217. Villaschi, S., and Nicosia, R.F. (1993). Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am. J. Pathol. 143, 181-190.
218. Villaschi, S., and Nicosia, R.F. (1994). Paracrine interactions between fibroblasts and endothelial cells in a serum-free co-culture model: Modulation of angiogenesis and collagen gel contraction. Lab. Invest. 71, 291-299.
219. Villaschi, S., Nicosia, R.F., and Smith, M. (1994). Isolation of a morphologically and functionally distinct muscle cell type from the intimai aspect of the normal rat aorta. Evidence for smooth muscle cell heterogeneity. In Vitro Cell. Dev. Biol. 30A, 589-595.
220. Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J., and Klagsburn, M. (1987). Endothelial-cell derived basic fibroblast growth factor. Synthesis and deposition into the subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84, 2292-2296.
221. Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Frances, N., Wahl, L. M., Roberts, A. B., and Sporn, M. B. (1987). Transforming growth factor type-β induces monocytes chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788-5792.
222. Warner, S. J. C., and Libby, P. (1989). Human vascular smooth muscle cells: Target and source of tumor necrosis factor. J. Immunol. 142, 100-109.
223. Weissberg, P. L., Witchell, C., Davenport, A. P., Hesketh, T. R., and Metcalfe, J. C. (1990). The endothelial peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 85, 257-262.
224. Williams, R. G. (1959). Experiments on the growth of blood vessels in thin tissue and in small autografts. Anat. Rec. 133, 465-485.
225. Wilting, J., and Christ, B. (1989). An experimental and ultrastructural study on the development of the avian choroid plexus. Cell Tissue Res. 255, 487-494.
226. Wilting, J., Brand-Saberi, B., Kurz, H., and Christ, B. (1995a). Development of the embryonic vascular system. Cell. Mol. Biol. Res. 41, 219-232.
227. Wilting, J., Brand-Saberi, B., Huang, R., Zhi, Q., Kontges, G., Ordahl, C. P., and Christ, B. (1995b). Angiogenic potential of the avian somite. Dev. Dynam. 202, 165-171.
228. Woessner, J. F. (1994). The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci. 732, 11-21.
229. Wu, H. M., Huang, Q., Yuan, Y., and Granger, H. (1996a). VEGF induces NO-dependent hyperpermeability in coronary venules. Am. J. Physiol. 271, H2735-H2739.
230. Wu, H. M., Yuan, Y., McCarthy, M., and Grager, H. (1996b). Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am. J. Physiol. 271, H1087-H1093.
231. Yang, J. T., Rayburn, H., and Hynes R. O. (1993). Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 119, 1093-1105.
232. Yoshizumi, M., Korembanas, S., Temizer, D. H., Cambria, R. P., Quertemous, T., and Lee, M. E. (1992). Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 267, 9467-9469.
233. Zagzag, D., Friedlander, D. R., Dosik, J., Chikaramane, S., Chan, W., Greco, A., Allen, J. C., Dorovini-Zis, K., and Grumet M. (1996). Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res. 56, 182-189.
234. Ziada, A. M. A. R., Hudlicka, O., Tyler, K. R., and Wright, A. J. A. (1984). The effect of long term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc. Res. 18, 724-732.
235. 1 and copper in angiogenesis. J. Natl. Cancer Inst. 69, 475-482.
236. Ziche, M., Morbidelli, L., Masini, E., Amerin, S., Granger, H. J., Maggi, C. A., Geppetti, P., and Ledda, F. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94, 2036-2044.
237. Ziehe, M., Parenti, A., Ledda, F., Dell'Era, P., Granger, H. J., Maggi, C. A., and Presta, M. (1997). Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res. 80, 845-852.